Furthermore, through the pharmacological experiment, we predict that HH can regulate VEGFA, VEGFR2, and eNOS via the HIF-1 signaling pathway and VEGF signaling pathway to promote angiogenesis and alleviate cerebral ischemia injury. The gene discussed is NOS3; the disease is Cerebral ischemia.